Spain Faces Supply Shortage of Critical Cancer Drug Tronoxal Until April 2026
Spain's health agency warns of a shortage of the cancer drug Tronoxal until April 2026 due to manufacturing issues, urging cautious use and alternative supplies.
Prescription drug
All prescription drug news
Spain Approves Pioneering Targeted Radioligand Therapy for Advanced Prostate Cancer
Spain has officially approved Pluvicto, the first targeted radioligand therapy for metastatic prostate cancer, improving survival and quality of life for patients with advanced disease.